文献速递牙体牙髓病

2%甲哌卡因与4%阿替卡因在下颌磨牙症状性不可逆性牙髓炎患者下牙槽神经阻滞成功率中的比较:一项随机双盲单中心临床试验

Inferior alveolar nerve block success of 2% mepivacaine versus 4% articaine in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized double-blind single-centre clinical trial.
PubMed 文献 · Int Endod J · 2022-08-20

这项随机双盲单中心临床试验纳入330例下颌磨牙症状性不可逆性牙髓炎患者,比较2%甲哌卡因与4%阿替卡因下牙槽神经阻滞成功率。总体麻醉成功率甲哌卡因组35.8%、阿替卡因组41.2%,差异无统计学意义;两组术中疼痛强度及补充麻醉需求均无显著差异。

要点

  • 2%甲哌卡因与4%阿替卡因下牙槽神经阻滞总体成功率相似,差异无统计学意义。
  • 甲哌卡因组补充麻醉需求43.6%,阿替卡因组38.2%,差异无统计学意义。
  • 术中疼痛强度与术前疼痛强度和牙位相关,补充麻醉需求与术前疼痛水平和年龄相关。

核心结论

  • 2%甲哌卡因与4%阿替卡因对下颌磨牙症状性不可逆性牙髓炎的下牙槽神经阻滞成功率相似。
  • 牙髓治疗术中疼痛体验可能与术前疼痛、牙位和年龄相关。

研究设计与样本

  • 随机双盲单中心临床试验,纳入330例下颌磨牙症状性不可逆性牙髓炎伴中重度疼痛患者。
  • 患者随机接受3.6 ml 2%盐酸甲哌卡因含1:100 000肾上腺素或3.4 ml 4%盐酸阿替卡因含1:100 000肾上腺素(n=165)。
  • 在开髓洞形制备和根管器械操作期间用11点数字评定量表评估术中疼痛强度。
  • 总体成功定义为整个治疗过程中患者无痛至轻度疼痛且无需补充麻醉;同时记录补充麻醉需求发生率。
  • 使用Mann-Whitney U检验和卡方(χ2)检验进行统计分析,计算麻醉失败的相对危险度(RR)及95%置信区间(CI),并用多因素回归分析评估易感因素对结局变量的影响。

主要发现

  • 两组基线变量均衡(p > .05)。
  • 开髓洞形制备和根管器械操作期间的术中疼痛强度两组相似(p > .05)。
  • 术中疼痛强度与术前疼痛强度和牙位相关(p < .05)。
  • 总体麻醉成功率甲哌卡因组35.8% vs 阿替卡因组41.2%(p > .05),麻醉失败的相对危险度[95% CI]为1.09 [0.92, 1.30]。
  • 补充麻醉需求发生率甲哌卡因组43.6% vs 阿替卡因组38.2%(p > .05;RR [95% CI]:1.14 [0.88, 1.48])。

关键数值与推荐

  • 总体麻醉成功:甲哌卡因组35.8% vs 阿替卡因组41.2%(p > .05)。
  • 麻醉失败相对危险度[95% CI]:1.09 [0.92, 1.30]。
  • 补充麻醉需求:甲哌卡因组43.6% vs 阿替卡因组38.2%(p > .05;RR [95% CI]:1.14 [0.88, 1.48])。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The aim of this study was to assess inferior alveolar nerve block (IANB) success of 2% mepivacaine (Scandonest 2%, Septodont, France) and 4% articaine (Septanest 4%, Septodont) in patients with symptomatic irreversible pulpitis (SIP) in mandibular molars during access cavity preparation and instrumentation. METHODOLOGY: Three hundred and thirty patients with moderate-to-severe pain in mandibular molars with SIP randomly received either 3.6 ml 2% mepivacaine hydrochloride with 1:100 000 adrenalin or 3.4 ml 4% articaine hydrochloride with 1:100 000 adrenalin (n = 165). Intraoperative pain (IOP) intensity was assessed during access cavity preparation and canal instrumentation using 11-point Numerical Rating Scale (NRS). Overall success was considered if the patient felt no-to-mild pain without the need for supplemental anaesthesia throughout treatment; the incidence of need for supplemental anaesthesia was also recorded. Data were statistically analysed using Mann-Whitney U- and Chi-squared (χ2 ) tests. Relative risk (RR) and 95% confidence interval (CI) of anaesthetic failure were calculated. The effect of pre-disposing factors on outcome variables was assessed using multivariable regression analyses. None of the participants reported any adverse effects. RESULTS: Baseline variables were balanced between groups (p > .05). The IOP intensity during access cavity preparation and canal instrumentation was similar for both groups (p > .05). IOP intensity was associated with preoperative pain intensity and tooth type (p < .05). Overall anaesthetic success rate was 35.8% for mepivacaine and 41.2% for articaine (p > .05) with a relative risk of failure [95% CI] 1.09 [0.92, 1.30]. The need for supplemental anaesthesia occurred 43.6% and 38.2% with mepivacaine and articaine respectively (p > .05; RR [95% CI]: 1.14 [0.88, 1.48]). Preoperative pain level and age were associated with the need for supplemental anaesthesia. CONCLUSIONS: 2% mepivacaine and 4% articaine demonstrate similar IANB success rates for mandibular molars with SIP. Intraoperative pain experience during endodontic treatment can be associated with preoperative pain, tooth type and age.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Habib MFOM, Tarek S, Teama SME, et al. Inferior alveolar nerve block success of 2% mepivacaine versus 4% articaine in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized double-blind single-centre clinical trial. Int Endod J. 2022. PMID: 35947082. doi:10.1111/iej.13810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。